2022 annual financial data
Aldeyra Therapeutics 2022 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -62,679,987 USD and net income was -62,024,636 USD.
Operating cash flow was -56,637,187 USD.
Get free Aldeyra Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -62,679,987 USD
- Net income
- -62,024,636 USD
- Operating cash flow
- -56,637,187 USD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Aldeyra Therapeutics financial years